Cholesterol must be transported throughout the body because it is essential for human life, playing a role in producing many hormones like estrogen, progesterone, testosterone, and adrenal hormones. It is necessary for the synthesis of vitamin D, bile salts and is critical for cellular membrane health. While cholesterol is key to many healthy cell functions, it also can harm the body if it is allowed to reach abnormal blood concentrations. Excessive cholesterol particles can be trapped in the arterial wall forming deposits called plaque and restrict blood flow, damaging arteries and increasing the chances of blood clots and heart attack. This panels measures the standard cholesterol markers; Total Cholesterol,  LDL “bad cholesterol”, HDL “healthy cholesterol” and Triglycerides as the first step in assessing cardiovascular risk. 

Lipoproteins are particles that transport fat and cholesterol throughout the body. Apolipoprotein A1 (ApoA1) is the main protein found in HDL cholesterol. HDL particles carry excess cholesterol from arteries to the liver, where it can be removed from the body, limiting cholesterol buildup in the artery walls. A higher ApoA1 level indicates more HDL particles and a lower risk of heart disease. In contrast, ApoB is found on all potentially atherogenic (plaque forming) particles including LDL and can indicate decreased cholesterol clearance from the blood and an increased risk for cardiovascular disease. ApoB provides a more accurate measurement of all plaque forming particles.

Low density lipoprotein (LDL) exists either as larger, more buoyant particles or as smaller, compact particles called small dense LDL (sdLDL). sdLDL is more easily oxidized, penetrates the artery wall more readily and remains in circulation longer because it is cleared less efficiently by the liver, making it more atherogenic than larger LDL particles.

Lifestyle choices such as an inflammatory diet, lack of exercise, poor sleep and smoking, along with diabetes, environmental toxins, chronic infections, food sensitivities and hormone imbalance, can increase oxidative stress that damages LDL particles and creates oxidized LDL (OxLDL). The oxidation of LDL is one of the earliest steps in the development of atherosclerosis. Oxidized LDL is readily taken up by immune cells within the artery wall, where it drives inflammation and plaque formation, increasing the risk of heart disease. 

While cholesterol screening plays an important role in cardiovascular risk assessment, it does not provide a complete picture. Studies show that nearly half of all heart attacks and strokes occur in people with normal cholesterol levels. Chronic inflammation in the arteries contributes to elevated blood pressure, plaque formation and cardiovascular disease. High sensitivity C reactive protein (hs-CRP) is a general marker of systemic inflammation and tissue damage. Myeloperoxidase (MPO) reflects inflammatory activity at the inner surface of the artery wall, while lipoprotein associated phospholipase A2 (Lp-PLA2) reflects inflammation within the artery wall itself and is associated with plaque that is more prone to rupture. These markers identify the inflammatory side of heart disease and provide a direct target for a personalized plan.

Elevated homocysteine damages the endothelium, the inner lining of the arteries, making the vessel wall more vulnerable to oxidative stress, plaque formation and clotting. High levels are associated with an increased risk of heart disease and stroke. The body clears homocysteine with the help of folate, vitamin B12 and vitamin B6, so elevated levels can reflect low B vitamin status or genetic variations such as MTHFR.

Lipoprotein(a), or Lp(a), is an LDL like particle with an additional protein that makes its structure especially harmful to the arteries. It carries oxidized lipids that promote inflammation and plaque formation, and it interferes with the body’s ability to break down blood clots. Unlike most cholesterol markers, Lp(a) is determined largely by genetics, changes little with diet or exercise and can be elevated even when standard cholesterol levels appear healthy. Elevated Lp(a) affects roughly one in five people and raises the risk of heart attack and stroke independently of standard cholesterol levels. Because it is not included in a routine cholesterol panel, many people with elevated Lp(a) are unaware of it.Lipoprotein(a), or Lp(a), is an LDL like particle with an additional protein that makes its structure especially harmful to the arteries. It carries oxidized lipids that promote inflammation and plaque formation, and it interferes with the body’s ability to break down blood clots. Unlike most cholesterol markers, Lp(a) is determined largely by genetics, changes little with diet or exercise and can be elevated even when standard cholesterol levels appear healthy. Elevated Lp(a) affects roughly one in five people and raises the risk of heart attack and stroke independently of standard cholesterol levels. Because it is not included in a routine cholesterol panel, many people with elevated Lp(a) are unaware of it.

Blood markers help estimate cardiovascular risk, while a Coronary Artery Calcium Score (CAC) looks directly for physical evidence of plaque within the four arteries supplying the heart. This quick, noninvasive CT scan measures calcified plaque and translates it into a score that reflects the extent of coronary atherosclerosis. A score of zero means no calcified plaque was detected, while higher scores reflect a greater plaque burden and a higher risk of future cardiac events. A traditional stress test typically detects narrowing only once an artery is more than 70% blocked, while a calcium score can detect plaque before it restricts blood flow. Because plaque can build silently for years, the test may uncover cardiovascular disease before symptoms are apparent. Results provide a clearer picture of future risk and can help determine how aggressively cholesterol, inflammation and other cardiovascular factors should be addressed.